Phase 2, Rand, Placebo-Controlled, Double-Blind, Dose Ranging Study to Evaluating Safety/Efficacy of Gerilimzumab in Patients With Moderately to Severely Active Rheumatoid Arthritis Inadequately Treated With Methotrexate or TNFα Antagonist
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Jan 2017
At a glance
- Drugs Gerilimzumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Bird Rock Bio
- 07 Jun 2017 Biomarkers information updated
- 03 Jan 2017 According to a Bird Rock Bio media release, the company has received approval from CONEP, and ANVISA to conduct this study solely in Brazil.
- 15 Jun 2016 Planned initiation date changed from 1 Jan 2016 to 1 Nov 2016.